The UC Davis Department of Ophthalmology received a five-year, $3.6 million grant from the National Eye Institute to explore ...

Let’s get to know Dr. Brittany Setzer of the Missouri Eye Institute. Missouri Eye Institute’s conveniently located offices in ...

Now that summer is here and the school holidays are nearly upon us, many of us are planning time outdoors and travelling in ...

Children spending more time indoors and on screens is causing a sharp rise in myopia, with cases appearing younger and progressing faster. Early detection and outdoor breaks are key for prevention.

The global ophthalmic sutures market was valued at approximately USD 608.86 million in 2023 and is expected to experience a significant expansion, growing at a compound annual growth rate (CAGR) of ...

Meredith R. Klifto, MD, is an assistant professor of ophthalmology at the University of North Carolina School of Medicine, ...

According to a study published in 2024 in the American Medical Association's Journal of Ophthalmology, 79% of children and ...

It is projected that the global Ophthalmic Lasers Market will be valued at USD 976.8 million in 2024 and USD 1,561.0 million in 2034. During the projection period from 2024 to 2034, sales are expected ...

This systematic review comprehensively summarizes treatment approaches for all types of age-related macular degeneration (AMD ...

Treatments for uveitic macular edema, including systemic and local options, were among the topics debated at the Congress on Controversies in Ophthalmology.

Age-related macular degeneration (AMD) remains a leading cause of vision loss, but new therapies are reshaping its treatment.

In early research, OCU410ST, a gene therapy for Stargardt disease, demonstrated slowed lesion growth by 48% at the 12-month follow-up in evaluable treated eyes.